Karyn Aalami Goodman, MD, MS, an internationally recognized expert on gastrointestinal cancers, has joined the Icahn School of Medicine at Mount Sinai as Associate Director for Clinical Research at The Tisch Cancer Institute. She is also Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology.

Dr. Goodman comes to Mount Sinai from the University of Colorado Cancer Center, where she served as Associate Director of Clinical Research. She was the head of Gastrointestinal Radiation Oncology at Memorial Sloan Kettering Cancer Center from 2007 to 2015. She began her academic medicine career on the faculty at Stanford University in 2004.

At Mount Sinai, Dr. Goodman will be responsible for developing the infrastructure and resources to support cancer clinical trial research across the Mount Sinai Health System. Dr. Goodman has served with several organizations, including the American Society for Clinical Oncology, to establish national treatment guidelines and best practices, and is Co-chair of the National Cancer Institute Gastrointestinal Steering Committee.

“We are thrilled that Dr. Goodman has joined the Mount Sinai team. With her dual role in both the Department of Radiation Oncology and The Tisch Cancer Institute, she will be able to coordinate research for every aspect of oncologic care and help guide the growth of the department’s burgeoning research portfolio,” said Kenneth Rosenzweig, MD, Professor and Chair of Radiation Oncology at the Icahn School of Medicine at Mount Sinai.

Dr. Goodman’s research focuses on improving outcomes and reducing toxicity in patients with gastrointestinal malignancies. With extensive experience as Principal Investigator on clinical trials, she is involved in development of therapeutic protocols combining radiation, chemotherapy, targeted agents, and immunotherapy.

“I am delighted that Dr. Karyn Goodman, a leader in GI radiation oncology, has joined us as the Associate Director for Clinical Research at The Tisch Cancer Institute, a crucial position that oversees our entire clinical research enterprise. Dr. Goodman will be instrumental in growing our clinical trial footprint throughout our Health System, a top priority,” said Ramon Parsons, MD, PhD, Director of the Institute.

Dr. Goodman earned her MD from Stanford University and MS from Harvard School of Public Health. She completed an internship in internal medicine at Stanford and residency training in radiation oncology at Memorial Sloan-Kettering.

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on 

"Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by 

Karyn Aalami Goodman, MD, MS

Articles

Renowned Gastrointestinal Radiation Oncologist Hired to Lead Clinical Cancer Research at Mount Sinai